Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age yet is often undiagnosed. Learn more about HCM in this podcast series to discuss its impact with your patients.
Hypertrophic Cardiomyopathy Podcast Series
Claim This Podcastby American Heart Association
4.5(9 reviews)
18 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age yet is often undiagnosed. Learn more about HCM in this podcast series to discuss its impact with your patients.
Language
🇺🇲
Publishing Since
9/23/2020
1 verified contact email on file for Hypertrophic Cardiomyopathy Podcast Series
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 31, 2024
AHA HCM Clinical Update: 2024 Guideline for Management of Hypertrophic Cardiomyopathy
<p><strong><span style= "font-size: 11.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"> In this On Demand video, Dr. Steve Ommen and Dr. Carolyn Ho discuss recent updates to the 2024 Guideline for the Management of Hypertrophic Cardiomyopathy (HCM). Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atrial fibrillation to improve patient outcomes.</span></strong></p>
August 11, 2022
Needle in the Haystack? Screening Large Populations for HCM
<p>It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.</p>
June 27, 2022
HCM and New Pharmacological Agents
<p>Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.</p>
18 total episodes available
Deep-dive analytics for Hypertrophic Cardiomyopathy Podcast Series
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Hypertrophic Cardiomyopathy Podcast Series?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.